ArticlePractical radiation oncology
Association of Patient Comorbidities With Treatment Regret Among Patients With Localized Prostate Cancer - Results From a Population-Based Cohort.
Article in Practical radiation oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeDecision regret is a well-established negative outcome in prostate cancer. We hypothesized that baseline comorbidities, which impact treatment tolerability, are associated with regret. METHODS AND MATERIALS: In a prospective, population-based cohort of patients with prostate cancer, patient-reported regret was assessed at 12 months after treatment using a validated measure. Comorbidities were assessed using medical record abstraction and scored using the validated National Cancer Institute Comorbidity Index. Multivariable logistic regression was used to assess the association between the comorbidity score and regret, accounting for treatment-related symptoms, treatment received, and sociodemographic measures.
resultsThis was a diverse cohort, comprising 25.3% Black patients and 24.2% living in rural areas. A total of 108 out of 981 patients (11%) reported regret. In multivariable analysis, comorbidity score (odds ratio [OR], 1.58; p < .05), not being married (OR, 1.72; p = .04), worsening of bowel symptoms (OR, 2.12; p < .01), and worsening of urinary obstruction/irritation (OR, 1.60; p = .05) were associated with decision regret. In addition, radiation therapy was associated with less regret compared with radical prostatectomy (OR, 0.48; p = .015).
conclusionsAmong men with localized prostate cancer, baseline comorbidity burden was associated with increased decision regret. These results illustrate the importance of assessing baseline comorbidities and incorporating their consideration into the treatment decision-making process, ensuring that patients have realistic expectations and make informed decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.